Characteristics | Model 1 | Model 2 | Model 3 | |
---|---|---|---|---|
Product bid upon | Intercept | 0.97 | −1.60 | −1.20 |
(0.71)+ | (0.72) | (0.72) | ||
Nicorette | 0.89*** | 0.89*** | 0.89*** | |
(0.13) | (0.13) | (0.13) | ||
Ariva | 0.35*** | 0.35*** | 0.37*** | |
(0.13) | (0.13) | (0.13) | ||
In treatment where offered, but rejected opportunity to take a trial, relative to control group | Offered but rejected Snus | −0.54 | −0.06 | −0.13 |
(0.39) | (0.35) | (0.35) | ||
Offered but rejected Nicorette | 0.95** | 0.87** | 0.50 | |
(0.46) | (0.41) | (0.40) | ||
Offered but rejected Ariva | −0.08 | 0.05 | 0.01 | |
(0.46) | (0.41) | (0.40) | ||
In treatment where offered, and accepted opportunity to take a trial, relative to control group | Tried Snus | −0.07 | 0.11 | 0.08 |
(0.42) | (0.38) | (0.37) | ||
Tried Nicorette | 0.20 | 0.27 | 0.23 | |
(0.38) | (0.34) | (0.33) | ||
Tried Ariva | 0.18 | −0.04 | −0.06 | |
(0.38) | (0.34) | (0.33) | ||
Age | −0.00 | 0.01 | 0.00 | |
(0.01) | (0.01) | (0.01) | ||
Income | −0.09 | −0.08 | −0.06 | |
(0.10) | (0.09) | (0.09) | ||
Education | 0.12 | −0.08 | 0.15 | |
(0.11) | (0.09) | (0.10) | ||
Female | 0.15 | 0.14 | 0.11 | |
(0.28) | (0.25) | (0.24) | ||
Race/Ethnicity | Black vs. white | 0.16 | 0.03 | −0.01 |
(0.32) | (0.28) | (0.29) | ||
Other vs. white | 0.57 | 0.05 | 0.13 | |
(0.48) | (0.43) | (0.42) | ||
State | South Carolina (vs. New York) | −0.82 | 0.09 | 0.03 |
(0.31) | (0.29) | (0.30) | ||
Pennsylvania (vs. New York) | −1.04*** | −0.87*** | −0.84*** | |
(0.32) | (0.29) | (0.28) | ||
Ever used smokeless tobacco | 0.10 | 0.09 | 0.04 | |
(0.29) | (0.26) | (0.25) | ||
Worried about their quality of life because of smoking | −0.01 | 0.06 | −0.01 | |
(0.24) | (0.22) | (0.21) | ||
Estimate of the cost of smokeless tobacco products | 0.02** | 0.02*** | 0.02*** | |
(0.01) | (0.01) | (0.01) | ||
Bid for cigarettes | 0.40*** | 0.38*** | ||
(0.05) | (0.05) | |||
Participant preferred menthol cigarettes | −0.06 | |||
(0.23) |